heally tirzepatide Cost Guide for Those Who Want to Lose Weight Online weight loss prescription, GLP-1

After a 36-week lead-in, participants had lost 20.9% of body weight

The glucagon-like peptide-1 receptor agonist (GLP-1 RA) is already approved for use in the treatment of obesity and for weight management

Key domains requiring structured oversight include: Pancreatitis and gallbladder disease Progression of diabetic retinopathy Severe gastrointestinal intolerance Visual loss and rare opticnerve complications Nutritional/metabolic issues with rapid weight reduction In India, where continuity of care is variable and prescribing often occurs outside endocrinology, these risks can be underrecognised or misattributed

Heres how GLP-1 impacts the food and beverage industry in 2026.

Discover how to eat carbs smartly while on treatment and maintain steady progress toward your goals